Key result
HbA1c ≥8% is linked to ~160% higher odds of subclinical ECG abnormalities in diabetes.
Why the study?
Type 2 diabetes mellitus predisposes to subclinical cardiovascular abnormalities even without overt cardiac disease, but the prevalence and predictors of ECG changes in this population are not well defined.
Does routine 12-lead ECG screening detect subclinical cardiovascular abnormalities in asymptomatic patients with Type 2 Diabetes Mellitus?
Cross-Sectional (n=200)
Yes
Does routine 12-lead ECG screening detect subclinical cardiovascular abnormalities in asymptomatic patients with Type 2 Diabetes Mellitus?
Odds Ratio: 2.6 (95% CI 1.5–4.4)
Absolute Event Rate: 77.1% vs 20%
p-value: p=0.001
Subclinical ECG abnormalities are highly prevalent (44%) in asymptomatic T2DM patients, particularly those with longer disease duration and poor glycemic control, suggesting a role for routine ECG screening to detect early cardiovascular risk.
HbA1c ≥8% associated with subclinical ECG abnormalities in T2DM; hypothesis-generating for screening, needs prospective validation.
Background: Type 2 diabetes mellitus (T2DM) predisposes to subclinical cardiovascular abnormalities, even in the absence of overt cardiac disease. Electrocardiography (ECG) is a simple, non-invasive tool to detect early changes that may indicate silent cardiovascular risk. Objective: To evaluate the prevalence and pattern of ECG changes in T2DM patients without previously diagnosed cardiac disease and to identify predictors of such abnormalities. Methods: A cross-sectional study was conducted on 200 patients with T2DM attending four different tertiary care hospitals across India for period of one Year. Patients with known ischemic heart disease, heart failure, hypertension, or renal failure were excluded. Standard 12-lead ECGs were recorded and analyzed for abnormalities. Patients were stratified by duration of diabetes and glycemic control (HbA1c). Statistical analysis included Chi-square tests and multivariate logistic regression. Results: ECG abnormalities were observed in 88 patients (44%). Common findings included QTc prolongation (18%), ST-T changes (15%), left ventricular hypertrophy (8%), bundle branch block (5%), and resting tachycardia (4%). ECG changes were significantly more frequent in patients with diabetes duration >10 years (62% vs. 32%, p<0.01) and HbA1c ≥8% (57% vs. 28%, p<0.001). Logistic regression identified diabetes duration >10 years (OR 2.1; 95% CI 1.3-3.5; p=0.002) and HbA1c ≥8% (OR 2.6; 95% CI 1.5-4.4; p=0.001) as independent predictors of ECG abnormalities. Conclusion: Subclinical ECG changes are common in T2DM patients without overt cardiac disease, particularly in those with longer disease duration and poor glycemic control. Routine ECG screening may help detect early cardiovascular risk and enable timely intervention.
No takes yet. Share an insight, caveat, or question.
Tangadi et al. (2025) conducted a cross-sectional in Type 2 diabetes mellitus without known cardiac disease (n=200). HbA1c ≥8% vs. HbA1c <7% was evaluated on ECG abnormalities (OR 2.6, 95% CI 1.5-4.4, p=0.001). In patients with type 2 diabetes without known cardiac disease, HbA1c ≥8% was an independent predictor of subclinical ECG abnormalities (OR 2.6).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: